ProShare Advisors
VYGR icon

ProShare Advisors’s Voyager Therapeutics VYGR Stock Holding History

ProShare Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,116
Closed -$43.7K – 2036
2025
Q4 		$43.7K Buy
+11,116
New +$49.2K ﹤0.01% 1971
2025
Q3 		– Sell
-11,618
Closed -$36.1K – 2123
2025
Q2 		$36.1K Sell
11,618
-803
-6% -$2.59K ﹤0.01% 2028
2025
Q1 		$42K Sell
12,421
-3,122
-20% -$14.6K ﹤0.01% 1969
2024
Q4 		$88.1K Sell
15,543
-8,311
-35% -$53.6K ﹤0.01% 2097
2024
Q3 		$140K Buy
+23,854
New +$173K ﹤0.01% 1819
2024
Q2 		– Sell
-10,876
Closed -$101K – 2016
2024
Q1 		$101K Buy
+10,876
New +$91.8K ﹤0.01% 1820
2021
Q2 		– Sell
-12,116
Closed -$57K – 2408
2021
Q1 		$57K Buy
12,116
+606
+5% +$4.13K ﹤0.01% 2219
2020
Q4 		$82K Buy
+11,510
New +$111K ﹤0.01% 2013
2020
Q1 		– Sell
-11,288
Closed -$157K – 1582
2019
Q4 		$157K Sell
11,288
-1,461
-11% -$21.2K ﹤0.01% 1639
2019
Q3 		$219K Sell
12,749
-272
-2% -$5.71K ﹤0.01% 1398
2019
Q2 		$354K Sell
13,021
-392
-3% -$8.97K ﹤0.01% 1156
2019
Q1 		$257K Buy
13,413
+137
+1% +$1.78K ﹤0.01% 1337
2018
Q4 		$125K Sell
13,276
-2,576
-16% -$33.1K ﹤0.01% 1447
2018
Q3 		$300K Sell
15,852
-557
-3% -$10.7K ﹤0.01% 1353
2018
Q2 		$321K Sell
16,409
-625
-4% -$12.4K ﹤0.01% 1346
2018
Q1 		$320K Sell
17,034
-2,804
-14% -$60.6K ﹤0.01% 1285
2017
Q4 		$329K Buy
+19,838
New +$340K ﹤0.01% 1336

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ProShare Advisors's VYGR Position: Q1 2026 in Review

ProShare Advisors sold out of Voyager Therapeutics (VYGR) in Q1 2026, closing a stake of 11,116 shares — an estimated $43.7K sold.

ProShare Advisors first reported a position in VYGR in Q4 2017 and held it in 17 quarters. The position peaked at $354K in Q2 2019. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • ProShare Advisors reported no remaining Voyager Therapeutics position as of Q1 2026 after selling out during the quarter.
  • ProShare Advisors sold 11,116 Voyager Therapeutics shares in Q1 2026, an estimated $43.7K.
  • ProShare Advisors first reported a position in Voyager Therapeutics in Q4 2017 and held it in 17 quarters.
  • ProShare Advisors's Voyager Therapeutics position peaked at $354K in Q2 2019.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.